Michael Gelband’s GE HealthCare GEHC Stock Holding History

Michael Gelband’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-826,189	Closed	-$61.2M	–	1713
2025 Q2	$61.2M	Buy	+826,189	New	+$57.5M	0.54%	24

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's GEHC Position: Q3 2025 in Review

Michael Gelband sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 826,189 shares — an estimated $61.2M sold.

Michael Gelband first reported a position in GEHC in Q2 2025 and held it in 1 quarter. The position peaked at $61.2M in Q2 2025. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

Michael Gelband reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
Michael Gelband sold 826,189 GE HealthCare shares in Q3 2025, an estimated $61.2M.
Michael Gelband first reported a position in GE HealthCare in Q2 2025 and held it in 1 quarter.
Michael Gelband's GE HealthCare position peaked at $61.2M in Q2 2025.
1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.